These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15320742)

  • 21. Hyperpolarization of murine small caliber mesenteric arteries by activation of endothelial proteinase-activated receptor 2.
    McGuire JJ; Hollenberg MD; Bennett BM; Triggle CR
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1103-12. PubMed ID: 15644953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteinase-activated receptor2 agonists upregulate granulocyte colony-stimulating factor, IL-8, and VCAM-1 expression in human bronchial fibroblasts.
    Ramachandran R; Morice AH; Compton SJ
    Am J Respir Cell Mol Biol; 2006 Jul; 35(1):133-41. PubMed ID: 16498082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and function of proteinase-activated receptor 2 in human bronchial smooth muscle.
    Schmidlin F; Amadesi S; Vidil R; Trevisani M; Martinet N; Caughey G; Tognetto M; Cavallesco G; Mapp C; Geppetti P; Bunnett NW
    Am J Respir Crit Care Med; 2001 Oct; 164(7):1276-81. PubMed ID: 11673222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteinase activated receptor-2 counterbalances the vascular effects of endothelin-1 in fibrotic tight-skin mice.
    Roviezzo F; Brancaleone V; Mattera Iacono V; Bertolino A; De Cunto G; Vellecco V; Lungarella G; Lucattelli M; Cirino G
    Br J Pharmacol; 2017 Nov; 174(22):4032-4042. PubMed ID: 27625162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw.
    Vergnolle N; Hollenberg MD; Sharkey KA; Wallace JL
    Br J Pharmacol; 1999 Jul; 127(5):1083-90. PubMed ID: 10455252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal nitric oxide modulates vascular effects of a peptide activating protease-activated receptor 2.
    Cicala C; Morello S; Vellecco V; Severino B; Sorrentino L; Cirino G
    Cardiovasc Res; 2003 Nov; 60(2):431-7. PubMed ID: 14613873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B.
    Buddenkotte J; Stroh C; Engels IH; Moormann C; Shpacovitch VM; Seeliger S; Vergnolle N; Vestweber D; Luger TA; Schulze-Osthoff K; Steinhoff M
    J Invest Dermatol; 2005 Jan; 124(1):38-45. PubMed ID: 15654951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteinase-Activated Receptor-2 Sensitivity of Amplified TRPA1 Activity in Skeletal Muscle Afferent Nerves and Exercise Pressor Reflex in Rats with Femoral Artery Occlusion.
    Xing J; Li J
    Cell Physiol Biochem; 2017; 44(1):163-171. PubMed ID: 29131007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
    Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
    Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity.
    Roy SS; Saifeddine M; Loutzenhiser R; Triggle CR; Hollenberg MD
    Br J Pharmacol; 1998 Apr; 123(7):1434-40. PubMed ID: 9579740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward drugs for protease-activated receptor 2 (PAR2).
    Yau MK; Liu L; Fairlie DP
    J Med Chem; 2013 Oct; 56(19):7477-97. PubMed ID: 23895492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands.
    Kawabata A; Saifeddine M; Al-Ani B; Leblond L; Hollenberg MD
    J Pharmacol Exp Ther; 1999 Jan; 288(1):358-70. PubMed ID: 9862790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of Time-Dependent Changes to the Mechanisms of Vasodilation by Protease-Activated Receptor 2 in Metabolic Syndrome.
    Maruyama K; McGuire JJ; Kagota S
    Biol Pharm Bull; 2017; 40(12):2039-2044. PubMed ID: 29199228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping transmembrane residues of proteinase activated receptor 2 (PAR
    Suen JY; Adams MN; Lim J; Madala PK; Xu W; Cotterell AJ; He Y; Yau MK; Hooper JD; Fairlie DP
    Pharmacol Res; 2017 Mar; 117():328-342. PubMed ID: 27993717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanism.
    Nguyen C; Coelho AM; Grady E; Compton SJ; Wallace JL; Hollenberg MD; Cenac N; Garcia-Villar R; Bueno L; Steinhoff M; Bunnett NW; Vergnolle N
    Can J Physiol Pharmacol; 2003 Sep; 81(9):920-7. PubMed ID: 14614531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biased signaling: potential agonist and antagonist of PAR2.
    Kakarala KK; Jamil K
    J Biomol Struct Dyn; 2016 Jun; 34(6):1363-76. PubMed ID: 26295578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development of proteinase-activated receptor-2 modulators and the challenges involved.
    McIntosh KA; Cunningham MR; Bushell T; Plevin R
    Biochem Soc Trans; 2020 Dec; 48(6):2525-2537. PubMed ID: 33242065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteinase-activated receptor-2 (PAR2) and mouse osteoblasts: regulation of cell function and lack of specificity of PAR2-activating peptides.
    Georgy SR; Pagel CN; Wong DM; Sivagurunathan S; Loh LH; Myers DE; Hollenberg MD; Pike RN; Mackie EJ
    Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):328-36. PubMed ID: 19769607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2 as a potential therapeutic target.
    Kanke T; Takizawa T; Kabeya M; Kawabata A
    J Pharmacol Sci; 2005 Jan; 97(1):38-42. PubMed ID: 15655295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking.
    Stalheim L; Ding Y; Gullapalli A; Paing MM; Wolfe BL; Morris DR; Trejo J
    Mol Pharmacol; 2005 Jan; 67(1):78-87. PubMed ID: 15475570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.